Robert Kramer

Robert Kramer

Former President, Chief Executive Officer and DirectoratEmergent BioSolutions· In proxies 2021–2023

Pay in FY2023-33% from the year before

Robert Kramer was paid $5.1M in FY2023 (Dec), down 33%.

PayNo stock prices for these years
Pay is from the Summary Compensation Table of each Emergent BioSolutions proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Emergent BioSolutionsPublic company · 5 yr
    • Former President, Chief Executive Officer and Director2021 – Present · 5 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?